Choline: Alpha-GPC vs Citicoline vs Phosphatidylcholine, and Why Most Adults Under-Consume

What is choline?

Choline is a quaternary ammonium compound — a small, water-soluble molecule that the body uses for four broad jobs: building cell membranes (as phosphatidylcholine and sphingomyelin), making the neurotransmitter acetylcholine, donating methyl groups (after conversion to betaine), and packaging fat for export from the liver as VLDL.

The body can synthesize some choline endogenously via the PEMT pathway (phosphatidylethanolamine N-methyltransferase), particularly when folate and methionine are abundant. But endogenous synthesis is not enough to meet most people's needs, which is why choline was formally classified as an essential nutrient by the Institute of Medicine in 1998 — diet supply matters.

For source documents see the IOM 1998 DRI report and the NIH Office of Dietary Supplements choline factsheet.

Evidence-based benefits of choline supplementation

1. Liver health and NAFLD prevention

The most reliable, mechanistically clean effect of choline: deficiency causes hepatic steatosis. In tightly controlled metabolic-ward studies, removing choline from the diet of healthy adults reproducibly produces fatty liver and elevated liver enzymes within weeks; reintroducing choline reverses it. People with non-alcoholic fatty liver disease (NAFLD) are frequently observed to consume below the AI, and repletion has improved hepatic fat in some clinical trials.

2. Prenatal brain development

The strongest "more is better" evidence is in pregnancy. The Caudill 2018 trial at Cornell randomized pregnant women to 930 mg/day vs 480 mg/day of choline during the third trimester; infants in the higher-dose group had measurably better information-processing speed at 7, 12, and 13 months. Both AAP and ACOG have raised awareness — but many prenatal vitamins still under-dose choline (often providing <100 mg).

3. Cognitive function

Observational data (notably the Framingham Offspring Cohort) link higher dietary choline intake with better cognitive performance and white-matter integrity. RCTs in non-deficient adults are mixed. The strongest cognitive evidence is for citicoline: the early ICTUS pilot work suggested benefit in post-stroke recovery, though the larger CITICOLINE-STAR trial was negative. Net: probably useful in deficiency and possibly in specific neurologic recovery contexts; supraphysiologic doses for "brain enhancement" in healthy people remain unproven.

4. Athletic performance

Alpha-GPC may modestly improve power output and lower-body force production in small, mostly short-duration trials (e.g., Bellar et al. 2015, ~600 mg). The literature is preliminary and the effect sizes are small — interesting, not definitive.

5. Methylation and homocysteine

Choline → betaine → methionine is a parallel methylation pathway to folate/B12. Adequate choline can spare folate and help maintain normal homocysteine, which is why nutrition researchers treat choline, folate, and B12 as a metabolic team rather than independent nutrients.

Symptoms of choline deficiency

True dietary choline deficiency, induced in metabolic-ward studies, produces:

• Hepatic steatosis (fatty liver) — the cardinal finding
• Muscle damage — elevated creatine kinase (CK)
• Elevated ALT (liver enzyme) reflecting hepatocellular stress

In free-living populations, frank deficiency is rare but subclinical inadequacy is common — that's the NHANES "90% below AI" finding. Two groups have higher requirements:

• People with PEMT genetic variants (notably the rs12325817 SNP) — endogenous synthesis is impaired, so dietary supply must compensate.
• Pregnant and lactating women — fetal demand for choline is substantial, and estrogen-driven PEMT upregulation isn't enough to cover it in everyone.

The 5 supplement forms of choline, compared

"Choline" on a label can mean very different molecules. Here's how they compare:

For a deeper comparison, see Alpha-GPC vs Citicoline.

How much choline should you take?

Choline has an Adequate Intake (AI), not a formal RDA — the IOM concluded that the data weren't sufficient to set an RDA in 1998, and the AI has stood since.

• Women 19+: 425 mg/day
• Men 19+: 550 mg/day
• Pregnancy: 450 mg/day
• Lactation: 550 mg/day

Practical supplemental doses by goal:

• General supplementation: 250–500 mg/day, ideally paired with a diet that includes some egg yolk, soy, or liver.
• Cognitive use: Alpha-GPC 300–1,200 mg/day, or citicoline 250–500 mg/day.
• Liver / NAFLD support: ~500 mg/day baseline (alongside dietary and metabolic management — choline is not a stand-alone NAFLD treatment).

Tolerable Upper Intake Level (UL): 3,500 mg/day for adults — set primarily by hypotension and fishy body odor at higher chronic intakes.

Side effects and safety

At AI-range doses, choline is well tolerated. At doses approaching or exceeding the 3,500 mg/day UL, the classic constellation of side effects is:

• Fishy body odor — gut bacteria convert excess choline to trimethylamine (TMA), which is excreted via skin and breath. People with the rare metabolic condition trimethylaminuria (TMAU, or "fish-odor syndrome") are especially susceptible.
• Sweating
• Hypotension (low blood pressure) — relevant if you take blood-pressure medication
• GI upset — nausea, loose stools

Most people who take supplements at the AI or moderate supplemental dose do not experience any of these.

The TMAO question

Probably the most discussed open issue in choline science. Here's the chain of events:

1. Dietary choline (and L-carnitine, the relevant non-choline source) reaches the colon if not fully absorbed in the small intestine.
2. Specific gut bacteria convert it to trimethylamine (TMA).
3. TMA is absorbed and oxidized in the liver to trimethylamine N-oxide (TMAO).
4. The Hazen lab at the Cleveland Clinic and others have published observational human data linking elevated plasma TMAO with major adverse cardiovascular events.

However, the causal interpretation is contested:

• Causality not established. Plasma TMAO may be a marker of impaired renal clearance (the kidney clears TMAO) or of a specific cardiometabolically unhealthy gut microbiome composition, rather than a cause of disease.
• The fish paradox. Fish — especially saltwater species — contains substantial pre-formed TMAO and yet is consistently associated with lower, not higher, cardiovascular risk in epidemiology.
• The deficiency alternative is worse. The well-characterized consequence of inadequate choline intake is hepatic steatosis and progressive liver disease — a clearly bad outcome.

Practical takeaway: meeting the AI from food and reasonable supplementation is well-supported. Megadose choline supplementation in cardiovascular-risk populations is an open question — defensible if there's a clear indication (e.g., NAFLD, pregnancy under-intake) and a reason to think it matters more than TMAO theoretically might.

Drug interactions to know about

• Anticholinergic medications (e.g., tricyclic antidepressants, oxybutynin, scopolamine) — choline supplements could theoretically counteract their effect by raising acetylcholine substrate availability, but the clinical relevance is minimal at typical doses.
• Methotrexate and other anti-folate drugs — the choline → betaine → methionine pathway is metabolically related to folate-mediated methylation, so choline status is worth tracking in patients on long-term anti-folate therapy.
• Blood-pressure medications — high-dose choline can cause hypotension; people on antihypertensives should avoid megadoses.

Check our free interaction checker for a complete list.

Frequently asked questions

Related articles